ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

PeopleandPicks.com is Zacks' Community Website
Find great stocks and great stock pickers in our online community. It's social, it's profitable and it's Free! Join the fun at PeopleandPicks.com

Quote:

Search for Ticker

Free Membership

Search:

ESALY: Eisai Ltd - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research

EISAI LTD (OTC)
ESALY	35.39	-0.66	(-1.83%)	Vol. 125	14:52 ET

Eisai Co LTD is involved in the Biotechnology and Drug Industry. Their principle activities are the manufacture and sale of pharmaceutical products. Operations are carried out through the following divisions: Pharmaceuticals: veterinary drugs other food additives, livestock feed and pharmaceutical production systems and equipment. The Group has overseas consolidated subsidiaries in the United States, Canada, the United Kingdom, France, Germany, East Southeast Asia and South and Central America.

General Information

EISAI CO LTD

- -, - - Phone: - Fax: - Web: - Email: None

Industry	MED-DRUGS
Sector:	Medical

Fiscal Year End	March
Last Reported Quarter	09/30/09
Next EPS Date	-

Price and Volume Information

Zacks Rank
Yesterday's Close	36.05
52 Week High	42.44
52 Week Low	25.81
Beta	0.64
20 Day Moving Average	769.05
Target Price Consensus	35.87

% Price Change
4 Week	-0.17
12 Week	-2.33
YTD	-14.49

% Price Change Relative to S&P 500
4 Week	-1.25
12 Week	-7.91
YTD	-29.23

Share Information
Shares Outstanding (millions)	296.57
Market Capitalization (millions)	10,587.44
Short Ratio	0.00
Last Split Date	03/26/1996

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	N/A
Current Year EPS Consensus Estimate	2.34
Estimated Long-Term EPS Growth Rate	1.90
Next EPS Report Date	-

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	3.50
30 Days Ago	4.00
60 Days Ago	4.00
90 Days Ago	4.00

Fundamental Ratios

P/E
Current FY Estimate:	15.29
Trailing 12 Months:	21.25
PEG Ratio	8.05

EPS Growth
vs. Previous Year	111.66%
vs. Previous Quarter	-15.38%

Sales Growth
vs. Previous Year	-0.59%
vs. Previous Quarter:	-3.32%

Price Ratios
Price/Book	2.49
Price/Cash Flow	9.29
Price / Sales	-

ROE
09/30/09	-
06/30/09	11.44
03/31/09	11.22

ROA
09/30/09	-
06/30/09	4.32
03/31/09	4.30

Current Ratio
09/30/09	-
06/30/09	1.98
03/31/09	1.92

Quick Ratio
09/30/09	-
06/30/09	1.70
03/31/09	1.66

Operating Margin
09/30/09	-
06/30/09	6.12
03/31/09	6.14

Net Margin
09/30/09	-
06/30/09	8.79
03/31/09	9.02

Pre-Tax Margin
09/30/09	-
06/30/09	8.79
03/31/09	9.02

Book Value
09/30/09	-
06/30/09	14.36
03/31/09	14.45

Inventory Turnover
09/30/09	-
06/30/09	2.54
03/31/09	2.61

Debt-to-Equity
09/30/09	-
06/30/09	0.94
03/31/09	0.93

Debt to Capital
09/30/09	-
06/30/09	48.62
03/31/09	48.54


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research